Rock Creek Group, LP Revance Therapeutics, Inc. Transaction History

Rock Creek Group, LP

  • $1.05 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$12.46 - $27.81 $186,900 - $417,150
-15,000 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$11.66 - $20.15 $40,810 - $70,525
-3,500 Reduced 18.92%
15,000 $243,000
Q3 2019

Nov 13, 2019
BUY
$10.22 - $14.5 $35,770 - $50,750
3,500 Added 23.33%
18,500 $241,000
Q2 2019

Aug 14, 2019
BUY
$10.67 - $15.49 $160,050 - $232,350
15,000 New
15,000 $195,000

Others Institutions Holding RVNC

# of Institutions
214
Shares Held
83.4M
Call Options Held
656K
Put Options Held
424K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email